title: On-Body Injector: An Administration Device for Pegfilgrastim.
abstract: Many chemotherapy regimens used today require the support of a granulocyte-colony-stimulating factor for the prevention of life-threatening neutropenia. In March 2015, a delivery method was introduced for Neulasta® (pegfilgrastim) through an on-body injector (Onpro®), which may eliminate the need for patients to return for injection after chemotherapy, increase workflow, and allow more patients to be seen. The purpose of this study was to monitor the implementation of the Onpro delivery system in an outpatient facility.
authors.affiliation: Stony Brook University Cancer Center.
authors.forename: Linda J
authors.initials: LJ
authors.lastname: Mahler
authors.affiliation: Stony Brook University Cancer Center.
authors.forename: Regina
authors.initials: R
authors.lastname: DiBlasi
authors.affiliation: Stony Brook University Cancer Center.
authors.forename: Anielka
authors.initials: A
authors.lastname: Perez
authors.affiliation: Stony Brook University Cancer Center.
authors.forename: Jeannie
authors.initials: J
authors.lastname: Gaspard
authors.affiliation: Stony Brook University Cancer Center.
authors.forename: Dayna
authors.initials: D
authors.lastname: McCauley
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects; D015331:Cohort Studies; D016503:Drug Delivery Systems / Q000295:instrumentation*; D005260:Female; D000069585:Filgrastim / Q000008:administration & dosage*; D006401:Hematologic Agents / Q000008:administration & dosage; D006801:Humans; D007279:Injections, Subcutaneous / Q000295:instrumentation*; D008297:Male; D009369:Neoplasms / Q000175:diagnosis / Q000188:drug therapy; D009503:Neutropenia / Q000209:etiology / Q000517:prevention & control*; D009859:Oncology Nursing / Q000193:education; D010353:Patient Education as Topic / Q000379:methods; D061214:Patient Safety; D017060:Patient Satisfaction / Q000706:statistics & numerical data; D012189:Retrospective Studies
chemical_list: D006401:Hematologic Agents; D000069585:Filgrastim
keywords: febrile neutropenia; on-body injector; patient satisfaction; pegfilgrastim